Indivior Cuts $385M Deal To End Suboxone Antitrust Claims
Drugmaker Indivior Inc. said Monday that it had reached a $385 million settlement with direct purchasers in antitrust litigation over its opioid addiction treatment Suboxone, heading off a trial in multidistrict...To view the full article, register now.
Already a subscriber? Click here to view full article